<PAGE>
EXHIBIT 99.3
[NEW STRATEGIC TECHNOLOGIES LOGO]
ST SPIN, INC.
3445 PEACHTREE RD. NE, SUITE 1400
ATLANTA, GEORGIA 30326
[______________], 2000
DEAR STOCKHOLDER:
We are very pleased that you will soon be a stockholder of ST Spin, Inc.
("New Strategic Technologies"). New Strategic Technologies is the global market
leader in customized Pharmaceutical Relationship Management ("PRM") solutions
and interactive marketing services, helping pharmaceutical companies achieve
maximum return on their sales and marketing investment.
As part of IMS Health Incorporated ("IMS HEALTH"), the New Strategic
Technologies businesses have been known for providing outstanding service levels
and having in-depth knowledge of the pharmaceutical market. As an independent
company, our highest priority will be to integrate the unique industry leading
capabilities of the Clark-O'Neill and IMS Health Strategic Technologies
businesses to provide high value knowledge-based solutions to the
biopharmaceutical industry and healthcare system that optimize the development,
promotion and delivery of healthcare products and services globally.
We believe that the separation of our businesses from our corporate parent,
IMS HEALTH, will enhance our ability to grow our businesses aggressively, both
internally and through selective alliances and acquisitions. For the first time,
we will have the ability to offer our employees incentive opportunities linked
to New Strategic Technologies' performance as a stand-alone company, which we
believe will aid our efforts to enhance recruitment and performance.
New Strategic Technologies has applied for listing of its shares on the
Nasdaq National Market under the symbol "[XXX]".
Our board, management and employees are excited about our future as an
independent company and we look forward to your support and participation in our
success.
Sincerely,
Wayne P. Yetter
Chief Executive Officer
ST Spin, Inc.
